Literature DB >> 30936100

Candida in the Respiratory Tract Potentially Triggers Galactomannan Positivity in Nonhematological Patients.

M Aigner1, M Wanner1, P Kreidl1, C Lass-Flörl1, M Lackner2.   

Abstract

BAL fluid samples from critically ill patients shared a rate of 29% false-positive galactomannan results. We aimed to determine whether Candida species abundance in BAL fluid causes galactomannan (GM) positivity. A total of 89 Candida culture-positive BAL fluid samples from patients without suspicion of invasive aspergillosis (IA) were analyzed. GM results were correlated with Candida species abundance, Candida species quantity, and patient data. Candida species quantities of ≥104/ml and Candida glabrata abundance were significantly associated with positive GM results. The added diagnostic value of GM in BAL fluid for diagnosing IA in critically ill patients is limited.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  BAL fluid; antibiotics; antifungals; antigen; antimicrobials; aspergillosis; critical ill patients; cross-reactivity; galactomannan; intensive care

Mesh:

Substances:

Year:  2019        PMID: 30936100      PMCID: PMC6535542          DOI: 10.1128/AAC.00138-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity.

Authors:  Jorien D'Haese; Koen Theunissen; Edith Vermeulen; Hélène Schoemans; Greet De Vlieger; Liesbet Lammertijn; Philippe Meersseman; Wouter Meersseman; Katrien Lagrou; Johan Maertens
Journal:  J Clin Microbiol       Date:  2012-02-01       Impact factor: 5.948

2.  Intravenous PLASMA-LYTE as a major cause of false-positive results of platelia Aspergillus test for galactomannan detection in serum.

Authors:  Zdenek Racil; Iva Kocmanova; Martina Lengerova; Jana Winterova; Jiri Mayer
Journal:  J Clin Microbiol       Date:  2007-08-01       Impact factor: 5.948

3.  Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay.

Authors:  Jessica R Cummings; Ginger R Jamison; Jan W Boudreaux; Merry J Howles; Thomas J Walsh; Randall T Hayden
Journal:  Diagn Microbiol Infect Dis       Date:  2007-07-26       Impact factor: 2.803

4.  False-positive Aspergillus antigenemia due to blood product conditioning fluids.

Authors:  Pablo Martín-Rabadán; Paloma Gijón; Roberto Alonso Fernández; Mónica Ballesteros; Javier Anguita; Emilio Bouza
Journal:  Clin Infect Dis       Date:  2012-05-18       Impact factor: 9.079

Review 5.  Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.

Authors:  V Krcmery; A J Barnes
Journal:  J Hosp Infect       Date:  2002-04       Impact factor: 3.926

Review 6.  Invasive aspergillosis in the intensive care unit.

Authors:  Wouter Meersseman; Katrien Lagrou; Johan Maertens; Eric Van Wijngaerden
Journal:  Clin Infect Dis       Date:  2007-06-13       Impact factor: 9.079

7.  Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus.

Authors:  Yu-Tsung Huang; Chien-Ching Hung; Chun-Hsing Liao; Hsin-Yun Sun; Shan-Chwen Chang; Yee-Chun Chen
Journal:  J Clin Microbiol       Date:  2007-06-27       Impact factor: 5.948

8.  Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing.

Authors:  Tong-Yong Ng; Mei-Ling Kang; Ban-Hock Tan; Cecilia Cheng-Lai Ngan
Journal:  Med Mycol Case Rep       Date:  2013-12-16

9.  The diagnosis of invasive and noninvasive pulmonary aspergillosis by serum and bronchoalveolar lavage fluid galactomannan assay.

Authors:  Shuzhen Zhang; Sibu Wang; Zhe Wan; Ruoyu Li; Jin Yu
Journal:  Biomed Res Int       Date:  2015-01-22       Impact factor: 3.411

10.  Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.

Authors:  Maria Schroeder; Marcel Simon; Juri Katchanov; Charles Wijaya; Holger Rohde; Martin Christner; Azien Laqmani; Dominic Wichmann; Valentin Fuhrmann; Stefan Kluge
Journal:  Crit Care       Date:  2016-05-10       Impact factor: 9.097

View more
  5 in total

1.  Evaluation of a Novel Aspergillus Antigen Enzyme-Linked Immunosorbent Assay.

Authors:  Karl Dichtl; Ulrich Seybold; Steffen Ormanns; Heidi Horns; Johannes Wagener
Journal:  J Clin Microbiol       Date:  2019-06-25       Impact factor: 5.948

2.  Challenges with Utilizing the 1,3-Beta-d-Glucan and Galactomannan Assays To Diagnose Invasive Mold Infections in Immunocompromised Children.

Authors:  Alice J Hsu; Pranita D Tamma; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2021-08-18       Impact factor: 5.948

3.  Investigating Factors of False-Positive Results of Aspergillus Galactomannan Assay: A Case-Control Study in Intensive Care Units.

Authors:  Yu-Hsuan Hung; Hui-Hsiung Lai; Hui-Chuan Lin; Kuo-Shao Sun; Chung-Yu Chen
Journal:  Front Pharmacol       Date:  2021-12-20       Impact factor: 5.810

4.  Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis?

Authors:  Sarah Dellière; Emmanuel Dudoignon; Sébastian Voicu; Magalie Collet; Sofiane Fodil; Benoit Plaud; Benjamin Chousterman; Stéphane Bretagne; Elie Azoulay; Alexandre Mebazaa; François Dépret; Bruno Mégarbane; Alexandre Alanio
Journal:  J Clin Microbiol       Date:  2022-01-05       Impact factor: 5.948

5.  Accuracy of galactomannan testing on tracheal aspirates in COVID-19-associated pulmonary aspergillosis.

Authors:  Carla M Roman-Montes; Areli Martinez-Gamboa; Paulette Diaz-Lomelí; Axel Cervantes-Sanchez; Andrea Rangel-Cordero; Jose Sifuentes-Osornio; Alfredo Ponce-de-Leon; Maria F Gonzalez-Lara
Journal:  Mycoses       Date:  2021-02-13       Impact factor: 4.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.